Finally, we investigated whether LDR-IR affected the sensitivity of anti-cancer drugs targeting the cell cycle or Aurora kinase B, and interestingly found that pre-treatment with LDR-IR significantly reduced the sensitivity to paclitaxel or barasertib in TIG-3 but not in A549 cells. The gene discussed is AURKB; the disease is cancer.